[On the effect of SDDS in combination with pyrimethamine or sulfamonomethoxine on cysts of Toxoplasma gondii in NMRI mice (author's transl)].
D000284:Administration, Oral; D000818:Animals; D002908:Chronic Disease; D004357:Drug Synergism; D005260:Female; D005856:Germ-Free Life; D051379:Mice; D011739:Pyrimethamine / Q000494:pharmacology / Q000627:therapeutic use; D013450:Sulfones / Q000494:pharmacology* / Q000627:therapeutic use; D013997:Time Factors; D014122:Toxoplasma / Q000187:drug effects*; D014123:Toxoplasmosis / Q000188:drug therapy
D013450:Sulfones; D011739:Pyrimethamine
Uber die Wirkung von SDDS in Kombination mit Pyrimethamin oder Sulfamonomethoxin auf Zysten von Toxoplasma gondii in NMRI-Mäusen